Medicare Enrolled

Dr. Rajbir Minhas, M.D.

Pain Medicine · Cincinnati, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
4760 RED BANK RD STE 104, Cincinnati, OH 45227
5132714488
In practice since 2006 (20 years)
NPI: 1134175409 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Minhas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Minhas? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Minhas

Dr. Rajbir Minhas is a pain medicine specialist in Cincinnati, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Minhas performed 1,465 Medicare services across 325 unique beneficiaries.

Between the years covered by Open Payments, Dr. Minhas received a total of $75,144 from 60 pharmaceutical and/or device companies across 1427 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Minhas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 21% volume in OH $75,144 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,465
Medicare services
Top 21% in OH for pain medicine
325
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~73 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,033 $62 $134
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
223 $83 $190
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
166 $1 $12
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
26 $46 $105
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
17 $113 $247
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$75,144
Total received (2018-2024)
Avg $10,735/year across 7 years
Top 4% in OH for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
1,427
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$59,358 (79.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,786 (21.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$377
2023
$5,879
2022
$12,646
2021
$20,817
2020
$18,543
2019
$2,997
2018
$13,885

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Stryker Corporation
$156
Saluda Medical Americas, Inc.
$99
ABBVIE INC.
$65
Lundbeck LLC
$22
VERTEX PHARMACEUTICALS INCORPORATED
$21
Boston Scientific Corporation
$15
Top 3 companies account for 84.7% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan, Inc.
$17,707
AbbVie Inc.
$16,067
ABBVIE INC.
$13,853
Assertio Therapeutics, Inc.
$6,855
Supernus Pharmaceuticals, Inc.
$3,586
PFIZER INC.
$2,653
Teva Pharmaceuticals USA, Inc.
$1,329
Vertos Medical, Inc.
$1,159
Collegium Pharmaceutical, Inc.
$1,130
Takeda Pharmaceuticals U.S.A., Inc.
$966
Amgen Inc.
$933
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$885
Lilly USA, LLC
$681
BioDelivery Sciences International, Inc.
$457
Scilex Pharmaceuticals Inc.
$445
Novartis Pharmaceuticals Corporation
$437
Daiichi Sankyo Inc.
$408
Boston Scientific Corporation
$357
Biohaven Pharmaceutical Holding Company Ltd.
$333
ASSERTIO THERAPEUTICS, Inc.
$283
Biohaven Pharmaceuticals, Inc.
$256
Eisai Inc.
$245
Stryker Corporation
$245
IBSA Pharma Inc.
$239
Medtronic USA, Inc.
$207
ARBOR PHARMACEUTICALS, INC.
$200
Zyla Life Sciences
$195
Egalet US Inc
$192
Averitas Pharma Inc.
$184
Horizon Therapeutics plc
$173
Merck Sharp & Dohme LLC
$171
Abbott Laboratories
$156
Almatica Pharma LLC
$156
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$149
Pernix Therapeutics Holdings, Inc.
$148
Avanos Medical
$148
GRT US Holding, Inc.
$146
Axsome Therapeutics, Inc.
$135
Lundbeck LLC
$132
Nevro Corp.
$125
Upsher-Smith Laboratories LLC
$116
Saluda Medical Americas, Inc.
$99
SCILEX PHARMACEUTICALS INC.
$97
Nalu Medical, Inc.
$94
IDORSIA PHARMACEUTICALS US INC
$75
AstraZeneca Pharmaceuticals LP
$72
Merck Sharp & Dohme Corporation
$69
UPSHER-SMITH LABORATORIES LLC
$68
Kaleo, Inc.
$54
Zyla Life Sciences, Inc.
$51
Vertical Pharmaceuticals, LLC
$48
Purdue Pharma L.P.
$43
SANOFI-AVENTIS U.S. LLC
$30
VERTEX PHARMACEUTICALS INCORPORATED
$21
Neurocrine Biosciences, Inc.
$18
EISAI INC.
$17
Otsuka America Pharmaceutical, Inc.
$17
Shionogi Inc
$13
Azurity Pharmaceuticals, Inc.
$12
SPR Therapeutics, Inc
$7
Top 3 companies account for 63.4% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AIMOVIG · AJOVY · ARYMO ER · AUSTEDO · Aimovig · Amitiza · Auvelity · BELBUCA · BELSOMRA · BOTOX · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · CAMBIA · COMIRNATY · COOLIEF* COOLED RADIOFREQUENCY · Cambia · Dayvigo · ELYXYB - celecoxib · EMGALITY · ENTELLUS - XPRESS ENT DILATION SYSTEM · EVZIO · Eprontia · Evoke · FLECTOR · Flector · GENERAL - PAIN MANAGEMENT · GRALISE · Gralise · Horizant · INGREZZA · KRYSTEXXA · KYPHON Balloon Kyphoplasty · LICART · LORZONE · LUCEMYRA · LYRICA · Licart · MILD DEVICE KIT · MOTEGRITY · MOVANTIK · Morphabond ER · Motegrity · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · OXAYDO · OXTELLAR XR · PENNSAID · PROCLAIM · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RAYOS · RELEXXII · RELISTOR · RELISTOR ORAL · REXULTI · REYVOW · SILENOR · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SYMPROIC · SYNVISC-ONE · Senza Spinal Cord Stimulation System · Symproic · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · Tirosint · Trintellix · UBRELVY · VRAYLAR · VYEPTI · WaveWriter Alpha Prime 16 · XTAMPZA · Xtampza ER · ZAVZPRET · ZIPSOR · ZOHYDRO ER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zipsor · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (79%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for pain medicine in OH.

Looking for a pain medicine specialist in Cincinnati?
Compare pain medicines in the Cincinnati area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
5
Per 100K population
0.6
County median income
$70,816
Nearest hospital
BLUERIDGE VISTA HEALTH AND WELLNESS
2.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Minhas is a clinical cardiology specialist, with above-average Medicare volume (top 21% in OH), with speaking/promotional industry engagement in the top 4% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Minhas experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Minhas performed 1,033 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Minhas receive payments from pharmaceutical companies?
Yes. Dr. Minhas received a total of $75,144 from 60 companies across 1,427 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Minhas's costs compare to other pain medicines in Cincinnati?
Dr. Minhas's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Minhas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →